Humana is planning to pull its Medicare Advantage offerings from a significant share of U.S. counties ahead of the 2027 plan year, narrowing its footprint to roughly 85 percent of counties where it currently operates. The move comes as the Centers for Medicare and Medicaid Services has finalized payment policies and risk adjustment changes for contract year 2027 that tighten insurer margins, and as Humana itself has signaled a shift toward margin discipline over membership growth. For beneficiaries in affected counties, the practical result is that they will need to find alternative coverage during the next annual open enrollment period.
How CMS payment changes are squeezing Humana’s county-level math
The financial pressure behind Humana’s service-area reduction traces directly to CMS decisions on how Medicare Advantage plans will be paid starting in 2027. The agency’s 2027 announcement set a net average payment impact that incorporates updated risk adjustment models, normalization factor adjustments, and exclusions tied to chart review records. Together, these changes reduce the revenue insurers can expect for enrollees whose risk scores had been boosted by documentation practices rather than actual health status changes. Counties where Humana’s projected per-member revenue falls fastest relative to medical costs become the likeliest candidates for exit.
CMS also emphasized accountability and oversight in a separate communication outlining how its finalized payment policies are meant to strengthen program integrity. In that policy release, the agency underscored that risk adjustment refinements are intended to better align payments with true clinical need, not coding intensity. For insurers that had relied heavily on chart reviews and health risk assessments to bolster risk scores, this shift translates into a structural revenue headwind.
Humana’s own SEC filings reinforce this reading. In its first-quarter 2026 results, the company affirmed full-year 2026 adjusted financial guidance while describing ongoing cost pressures and membership trends in its Medicare Advantage segment. The filing frames service-area decisions as part of a broader effort to protect margins rather than chase enrollment volume, a theme Humana’s management had already introduced in fourth-quarter 2025 prepared remarks filed with the SEC. Management pointed to medical cost trends and reimbursement dynamics as key variables shaping where the company can viably offer plans.
A separate layer of pressure comes from the Contract Year 2027 Final Rule, which CMS published through the Federal Register and referenced in its payment communications. That rule adjusts Star Ratings measures and quality bonus payment mechanics. Plans that earn lower Star Ratings in certain counties lose access to bonus payments that can account for several percentage points of total revenue. When a county’s projected quality bonus shrinks at the same time its base payment rate faces normalization cuts, the combined effect can make continued participation financially unworkable. In such markets, Humana’s strategic response is increasingly to exit rather than absorb thinner margins.
Margin discipline versus enrollment growth at Humana
Humana’s leadership has been explicit about choosing profitability over geographic reach. The company’s fourth-quarter 2025 management remarks, filed as an exhibit with the SEC, described a strategy centered on retention and margin recovery rather than expansion into new or marginal markets. That language set the stage for the county-level pullbacks now taking shape for 2027. The first-quarter 2026 disclosure continued this theme, with guidance that prioritizes adjusted earnings stability over membership growth targets and highlights a focus on “sustainable” participation in Medicare Advantage.
Under this approach, counties that require rich supplemental benefits, aggressive broker commissions, or unusually tight provider contracts to stay competitive become prime candidates for retrenchment. Humana can redirect capital and operational resources toward markets where its scale, provider partnerships, and Star Ratings support stronger returns. The company has also emphasized efforts to improve care management and clinical programs, but those initiatives take time to translate into better quality scores and more favorable economics.
The hypothesis that dropped counties will show above-average margin compression once CMS releases bid-level data is testable but not yet confirmable. CMS publishes plan bid data and service-area files after the annual bid submission window closes, typically in the fall. Until those files become available, the specific financial calculus behind each county exit will not be visible to outside analysts. What is clear from Humana’s public filings and CMS’s payment framework is that the company is aligning its footprint with markets where 2027 revenue assumptions can comfortably cover medical costs and administrative expenses while still meeting its margin goals.
What affected beneficiaries should expect
For beneficiaries living in counties where Humana withdraws, the immediate consequence will be the need to select a new plan during the Medicare Advantage and Part D open enrollment window preceding the 2027 plan year. CMS typically requires insurers that exit a county to provide advance written notice and to work with regulators to ensure that enrollees understand their options. Those options may include switching to another Medicare Advantage plan available in the county or returning to traditional Medicare, potentially with a standalone Part D prescription drug plan.
Consumers in these markets should pay particular attention to how remaining plans are adjusting benefits and premiums in response to the same 2027 payment changes that drove Humana’s decision. While some competitors may see an opportunity to gain share, they are subject to the identical risk adjustment and quality bonus rules. That means richer benefits in the wake of Humana’s exit are not guaranteed and, in some counties, could be unlikely. As the 2027 landscape takes shape, Humana’s retrenchment underscores how regulatory shifts and corporate margin priorities can combine to reshape local Medicare Advantage choices, even when overall national enrollment in the program continues to grow.
Free for readers: The free Retirement Shield newsletter sends plain-English help keeping more of your money in retirement — the scams to dodge, the benefits you’re owed, and what’s changing with Social Security and Medicare, a couple times a week. Get the free newsletter.
